Loncar Cancer Immunotherapy ETF Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (20)

Latest Posts

About This Stock More About This Stock
5 ETFs Jump After Three-Day Rout: Will The Rally Last?
Article By: Sweta Killa
Thursday, September 10, 2020 11:58 AM EDT
Here are the ETFs that were at the forefront of the market rebound on Sep 9 and will continue to do so if market sentiments remain positive.
In this article: PBW, PTH, ARKQ, CNCR, FNGS Also: AZN, AAPL, MSFT, TSLA
Read
Moderna ETFs To Gain On New Positive COVID-19 Vaccine Data
Article By: Zacks Investment Research
Friday, August 28, 2020 6:31 PM EDT
The competition to come up with a coronavirus vaccine is opening up near-term opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide exposure to Moderna.
In this article: IBB, BBH, XBI, MRNA, CNCR, BTEC, IDNA, GERM
Read
Moderna - A Step Closer To Coronavirus Vaccine: ETFs To Gain
Article By: Zacks Investment Research
Sunday, June 14, 2020 3:44 PM EDT
The first company to start human clinical trials of its coronavirus vaccine candidate in the United States — Moderna — has informed that it is on schedule to initiate the final-stage clinical trial by July.
In this article: AZN, JNJ, BBH, MRNA, CNCR, IDNA Also: IBB, XBI
Read
3 ETFs For More Moderna Bets
Article By: Benzinga
Tuesday, May 19, 2020 10:50 AM EDT
Shares of biotechnology company Moderna Inc jumped 20% Monday on news that its mRNA-1273 coronavirus vaccine candidate is making positive progress.
In this article: CNCR, BTEC, IDNA, MRNA
Read
EC Top Precision Medicine Stocks
Article By: Fred Fuld
Sunday, January 19, 2020 1:13 PM EDT
In precision medicine, the focus is on identifying which approaches will be effective for which patients based on genetic, environmental, and lifestyle factors. For investors, there are a few stocks that participate in this industry.
In this article: BMRN, ILMN, VRTX, VRML, CNCR, IQV
Read

PARTNER HEADLINES

Latest Tweets for $CNCR

No tweets yet!